Are your affordability programs working hard enough?
Manufacturers invest billions, yet patient access challenges continue to grow.
Traditional affordability models are not built for today’s access challenges. As access becomes more complex, your affordability strategy should too.
EVERSANA leaders Graham Lane and Deanna Horner explore how an intelligent, connected, patient-first access strategy can turn affordability into a powerful driver of patient access, therapy adoption, and Gross-to-Net performance.
Read the POV to learn how to:
- Optimize affordability spend without sacrificing patient support
- Improve access visibility, decision-making, and outcomes through data-driven solutions
- Reduce barriers and improve program efficiency with intelligent copay design, direct access pathways, and marketplace-style adjudication
- Turn affordability into a strategic commercialization advantage
Author
Deanna helps payers and life sciences partners improve access, affordability, and patient outcomes across the pharmacy ecosystem. An experienced healthcare executive, Deanna is known for driving operational excellence, growth, and meaningful change at the…
Graham Lane is a Senior Vice President of Patient Services at EVERSANA. For more than 15 years, he has worked across the pharmaceutical industry to build and support best-in-class affordability programs to make access…